Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aggressive polyfibromatosis: a 10 year follow-up

Y C Lee1, H H Chan, M M Black

  • 1St John's Institute of Dermatology, St Thomas' Hospital, London, United Kingdom.

The Australasian Journal of Dermatology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaze and attention: Mechanisms underlying the therapeutic effect of optokinetic stimulation in spatial neglect.

Neuropsychologia·2024
Same author

YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells.

British journal of pharmacology·2014
Same author

Prevalence and extent of subclinical atherosclerosis in patients with psoriasis.

Journal of internal medicine·2012
Same author

Assessing the susceptibility status of Aedes albopictus on Penang Island using two different assays.

Tropical biomedicine·2011
Same author

Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation.

The British journal of dermatology·2010
Same author

Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.

Alimentary pharmacology & therapeutics·2008
Same journal

Allergic Contact Dermatitis Caused by Online-Purchased Black Henna Temporary Tattoos.

The Australasian journal of dermatology·2026
Same journal

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026
Same journal

Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era.

The Australasian journal of dermatology·2026
Same journal

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series.

The Australasian journal of dermatology·2026
Same journal

The Dermatologist's Role in Early PMOS Diagnosis.

The Australasian journal of dermatology·2026
Same journal

From Curriculum Variation to Clinical Capability: Advancing Dermatology Education in Australia.

The Australasian journal of dermatology·2026
See all related articles

Polyfibromatosis syndrome involves multiple fibrotic skin conditions. This case study details a 10-year follow-up of an aggressive form linked with joint disease, discussing its causes and treatment.

Area of Science:

  • Dermatology
  • Rheumatology
  • Genetics

Background:

  • Polyfibromatosis syndrome is a rare condition characterized by multiple cutaneous fibrotic disorders, such as Dupuytren's contracture and keloid formation.
  • Understanding the pathogenesis of this syndrome is crucial for effective management.

Observation:

  • A 10-year follow-up of a patient with an aggressive subtype of polyfibromatosis is presented.
  • This aggressive form is associated with erosive arthropathy, indicating a potential systemic component.

Findings:

  • The case highlights the long-term progression of polyfibromatosis and its association with joint destruction.
  • Detailed discussion on the underlying pathogenesis, including potential genetic and molecular factors, is provided.

Related Experiment Videos

Implications:

  • This study contributes to the understanding of polyfibromatosis syndrome, particularly its aggressive variants.
  • Management strategies for this uncommon condition are discussed, offering insights for clinicians.
  • Further research into the pathogenesis may reveal novel therapeutic targets for fibrotic diseases.